General Information of Drug (ID: DMRVQ5Z)

Drug Name
US9598431, 1 Drug Info
Synonyms
SCHEMBL18579631; BDBM302858; US9598431, 1; (S)-N-((5-(ETHYLSULFONYL)PYRIDIN-2-YL)METHYL)-5'-METHYL-1-((R)-1-(2-(TRIFLUOROMETHYL)PYRIMIDIN-5-YL)ETHYL)-4',5'-DIHYDROSPIRO[PIPERIDINE-4,7'-THIENO[2,3-C]PYRAN]-2'-CARBOXAMIDE; N-{[5-(Ethylsulfonyl)pyridine-2-yl]methyl}-5'-methyl-1-{1-[2-(trifluoromethyl)pyrimidin-5-yl]ethyl}-4',5'-dihydrospiro[piperidine-4,7'thieno[2,3-C]pyran]-2'-carboxamide
Cross-matching ID
PubChem CID
126644142
TTD Drug ID
DMRVQ5Z

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Patented Agent(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
US9598431, 5 DMXGF56 N. A. N. A. Patented [1]
US9598431, 2 DMILY1P N. A. N. A. Patented [1]
all-trans-4-oxo-retinoic acid DMM2R1N Discovery agent N.A. Investigative [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
RAR-related orphan receptor-beta (RORB) TTGB2LZ RORB_HUMAN Inhibitor [1]

References

1 Compounds useful for inhibiting ROR-gamma-t. US9598431.
2 All-trans retinoic acid is a ligand for the orphan nuclear receptor ROR beta. Nat Struct Biol. 2003 Oct;10(10):820-5.